Overview Financials News + Filings Key Docs Ownership
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
Tags Quarterly results
|
GALAPAGOS NV (GLPG)
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
08/04/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
06/15/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
06/13/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
06/12/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
06/07/2023 |
SC 13G
| EcoR1 Capital, LLC reports a 9.9% stake in Galapagos NV |
05/23/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
05/09/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
05/02/2023 |
6-K
| Quarterly results |
05/02/2023 |
6-K
| Quarterly results |
04/26/2023 |
6-K
| Quarterly results |
04/25/2023 |
6-K
| Quarterly results |
03/31/2023 |
6-K
| Quarterly results |
03/27/2023 |
6-K
| Quarterly results |
03/23/2023 |
20-F
| Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: |
03/23/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
02/28/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
02/24/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
02/14/2023 |
SC 13G/A
| EcoR1 Capital, LLC reports a 6.7% stake in Galapagos NV |
02/10/2023 |
6-K
| Quarterly results |
02/09/2023 |
SC 13G
| FMR LLC reports a 5.9% stake in GALAPAGOS NV |
02/08/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
01/19/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
|
"Corporate Presentation, titled J.P. Morgan Healthcare Conference, The information contained in slides numbered 6, 8, 9 and 18 featured in of this Report on Form 6-K, is hereby incorporated by reference into the Company's Registration Statements on Form S-8 (File Nos. 333-204567, 333-208697, 333-211834, 333-215783, 333-218160, 333-225263, 333-231765, 333-249416, 333-260500 and 333-268756)",
"Corporate Presentation, titled J.P. Morgan Healthcare Conference, The information contained in slides numbered 6, 8, 9 and 18 featured in of this Report on Form 6-K, is hereby incorporated by reference into the Company's Registration Statements on Form S-8 (File Nos. 333-204567, 333-208697, 333-211834, 333-215783, 333-218160, 333-225263, 333-231765, 333-249416, 333-260500 and 333-268756)" |
|
01/10/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
01/05/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
01/05/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
12/23/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
12/13/2022 |
6-K
| Quarterly results |
12/12/2022 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans: |
11/14/2022 |
6-K
| Quarterly results |
11/09/2022 |
6-K
| Quarterly results |
11/07/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
11/04/2022 |
6-K
| Quarterly results |
10/17/2022 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
10/06/2022 |
6-K
| Quarterly results |
|
|
|